Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Metrics to compare | 096530 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship096530PeersSector | |
---|---|---|---|---|
P/E Ratio | 36.2x | −15.0x | −0.6x | |
PEG Ratio | 0.03 | 0.07 | 0.00 | |
Price/Book | 1.0x | 1.6x | 2.6x | |
Price / LTM Sales | 2.7x | 7.6x | 3.1x | |
Upside (Analyst Target) | 64.1% | 47.9% | 52.1% | |
Fair Value Upside | Unlock | 7.3% | 8.2% | Unlock |